According to Huawei Yu Chengdong’s official microblogging release, “Huawei watches will be the first to support the high blood sugar risk assessment study, Huawei WATCH 4 series will be the first to support. After people authorize to join the research project and wear the watch for a period of time, the watch will inform the hyperglycemia risk level, thus further making people pay attention to a healthy lifestyle.” Huawei WATCH 4 series will be presented at Huawei’s new product launch on May 18.
According to the poster, this product is not a medical device, the measurement data and results are for reference only and are not used as a basis for diagnosis and treatment, the function requires users to join third-party professional medical institutions to initiate blood glucose health research to achieve, not applicable to users under the age of 18, type I diabetes, gestational diabetes and other particular types of diabetes population. Take the picture as an example, the hyperglycemia risk assessment can assess the kind of time in a week, such as medium risk, “there may be short-term blood sugar fluctuations, excessive intake of high sugar, high oil and high-fat diet may lead to the elevated risk of hyperglycemia”, the user can also click the button “start a new round of assessment The user can also click on the button “Start a new round of assessment.
Huawei WATCH 4 series flagship smartwatch was first unveiled at the European launch, Huawei WATCH 4 Pro with 48mm titanium case, has 1.5-inch LTPO AMOLED display, is covered with sapphire glass, and weighs 48 grams. Comparatively, the Huawei WATCH 4 is slightly smaller, with a 46mm stainless steel case.
